International Journal of Research and Reports in Hematology

Contributing Factors to the Occurrence of Stroke in Sub Saharian Sickle Cell Homozygous Patients

Mohamed Keita *

Clinical Hematology Department, Centre National de Transfusion Sanguine, Dakar, Senegal.

Moussa Seck

Clinical Hematology Department, Centre National de Transfusion Sanguine, Dakar, Senegal and Hematology Department, Cheikh Anta Diop University, Dakar, Senegal.

Sokhna Aissatou Touré

Clinical Hematology Department, Centre National de Transfusion Sanguine, Dakar, Senegal and Hematology Department, Cheikh Anta Diop University, Dakar, Senegal.

Elimane Seydi Bousso

Clinical Hematology Department, Centre National de Transfusion Sanguine, Dakar, Senegal.

Alioune Badara Diallo

Clinical Hematology Department, Centre National de Transfusion Sanguine, Dakar, Senegal.

Blaise Felix Faye

Clinical Hematology Department, Centre National de Transfusion Sanguine, Dakar, Senegal and Hematology Department, Cheikh Anta Diop University, Dakar, Senegal.

Saliou Diop

Clinical Hematology Department, Centre National de Transfusion Sanguine, Dakar, Senegal and Hematology Department, Cheikh Anta Diop University, Dakar, Senegal.

*Author to whom correspondence should be addressed.

---

Abstract

Introduction: Stroke is a major complication of sickle cell disease, with a high morbidity and mortality rate. This study aimed to determine the contributing factors to the occurrence of stroke in homozygous sickle cell disease patients. This is a study in Senegal and is first sub-Saharian report on SCD.

Patients and Methods: We conducted a case-control study among 66 homozygous sickle cell patients, including 22 with and 44 without stroke. Stroke was diagnosed based on imaging (CT and/or MRI). Socio-demographic, clinicobiological, and evolutionary aspects were recorded for each patient.

Results: The median age was 23 years (18 - 37) with a sex ratio (M/F) was 1.45. The most common age group was between 15 and 20 years (41.25%). The main diagnostic circumstances were persistent headache (54.5%) and hemiplegia (50%). The majority of patients had suffered an ischaemic stroke (77.3%), with a predominance of sylvian location (79.15%). Contributing factors were several VOCs / year >3, high hemoglobin S, low baseline hemoglobin, hyperleukocytosis, high hematocrit, thrombocytosis, high LDH, and high unconjugated bilirubin.

Conclusion: Stroke is a frightening and common complication of sickle cell disease, the occurrence of which is favored by the clinical severity of sickle cell disease and biological complications. Preventing these factors would reduce the risk of stroke in these patients.

Keywords: Sickle cell disease, cerebral vasculopathy, stroke, contributing factors

---

---

---

References

Steinberg MH. Genetic Etiologies for phenotypic diversity in sickle cell anemia. Scientific World Journal. 2009;9:46‑ 67.

Rennie KM, Scott JP, Panepinto JA, Hillery CA. Increased red cell adhesion is associated with overt stroke in Sickle Cell Disease. Blood. 2005;106(11):2320‑ 2320.

Earley CJ, Kittner SJ, Feeser BR, Gardner J, Epstein A, Wozniak MA, et al. Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology [en ligne]. 1998;51(1):169‑176.

[Accessed on 17 novembre 2022]

Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. The Lancet 2010;376 (9757):2018‑2031.

Bernaudin F, Verlhac C, Coïc L, et al. Effectiveness of early exploration by transcranial Doppler in the prevention of stroke: single-center experience of a cohort of children with sickle cell disease screened neonatally. Hematology. 2007; 2S,13 summary 3-27:29.

Bernaudin F, Verlhac S. Strokes in sickle cell patients: Contribution of transcranial Doppler and magnetic resonance imaging. Hematology 2008;14(1):25- 35.

Abdullahi SU, Wudil BJ, Bello-Manga H, Musa AB, Gambo S, Galadanci NA, et al. Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial. Pediatr Hematol Oncol. Févr. 2021;38(1):49- 64.

Diop S, Diop D, Seck M, Guèye Y, Faye A, Dièye TN, Touré Fall AO, Sall Diallo A, Thiam D, Diakhate L. Predictive factors of chronic complications of homozygous sickle cell disease in adults in Dakar (Senegal). Med Trop (March). 2010;70(5-6):471-4.

Schlotman AA, Donahue MJ, Kassim AA, Lee CA, Waddle SL, Pruthi S, et al. Intracranial and extracranial vascular stenosis as risk factors for stroke in Sickle cell disease. Pediatr Neurol. 2021;114:29‑34.

Munube D, Katabira E, Ndeezi G, Joloba M, Lhatoo S, Sajatovic M, et al. Prevalence of stroke in children admitted with sickle cell anemia to Mulago Hospital. BMC Neurol. 2016;16(1): 175.

Lawrence C, Webb J. Sickle cell disease and stroke: diagnosis and management. Curr Neurol Neurosci Rep. 2016;16(3):27.

OUATTARA Arouna. Cerebrovascular accidents in sickle cell patients aged 6 months to 15 years followed in Bamako by Gabriel Toure. University of Bamako Faculty of Medicine, Pharmacy and Ontostomatology; 2009.

Hassan A Al-Jafar, Raed Alroughani, Thamer A. Abdullah, Fatma Al-Qallaf. Neurological Complications in Sickle Cell Disease. International Journal of Clinical and Experimental Neurology. 2016;4 (1):9-18.

Steven A, Raghavan P, Rath TJ, Gandhi D. Neurologic and head and neck manifestations of sickle cell disease. Hematol Oncol Clin North Am. 2016; 30(4):779‑798.

DeBaun MR, Kirkham FJ. Central nervous system complications and management in sickle cell disease. Blood. 2016;127(7):829‑838. DOI: 10.1182/blood-2015-09-618579

Adoukonou Thierry, Accrombessi Donald, Agbétou Mendinatou, Houinato Dismand. Incidence of epilepsy after a stroke in Parakou in 2014. Pan Afr Med J. 2019;32:69.

Morel Y, Camara KA, Bangoura SA, Soumah D, Camara N, Cisse FA, et al. Stroke and major sickle cell disease in adults in Conakry-Guinea. Neurological Review. 2015;171:A42.

Herinirina NF, Ny LH, Herijoelison AR, Alson OA, Ahmad A. Transcranial doppler during sickle cell disease in malagasy children. Pan Afr Med J [online]; 2016.

Verlhac S, Bernadin F. Transcranial doppler in children with sickle cell disease. J Radiol. 2003;84:131-8.

Amlie-Lefond C, Flanagan J, Kanter J, Dobyns WB. The genetic landscape of cerebral steno-occlusive arteriopathy and stroke in Sickle Cell Anemia. J Stroke Cerebrovasc Dis. 2018;27(11):2897‑2904.

Strouse JJ, Lanzkron S, Urrutia V. The epidemiology, evaluation, and treatment of stroke in adults with sickle cell disease. Expert Rev Hematol. 2011;4(6):597- 606.

Dowling MM, Kirkham FJ. Stroke in sickle cell anemia is more than stenosis and thrombosis: the role of anaemia and hyperemia in ischaemia. Br J Haematol. 2017;176(2):151-153.

Verduzco LA, Nathan DG. Sickle cell disease and stroke. Blood. 2009:114 (25):5117‑5125.

Belisário AR, Silva CM, Velloso-Rodrigues C, Viana MB. Genetic, laboratory, and clinical risk factors in the development of overt ischemic stroke in children with sickle cell disease. Hematol Transfus Cell Ther. 2018;40(2):166‑181.

Dubert M, Elion J, Tolo A, Diallo DA, Diop S, Diagne I, et al. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa. Blood. 2017;130(20): 2215‑2223.